Pinton et al. [22] also observed over 60% lymphocytes (CD45+ cells) in fresh tumour cell suspensions using multicolour flow cytometry in 2018, with myeloid cells CD33+ HLA-DR+ representing the largest population (80.4% +/− 20.6%) of the CD45+ group, which was in agreement with our results. The gene discussed is PTPRC; the disease is neoplasm.